Dr Sikander Ailawadhi | CureTalks
Dr Sikander Ailawadhi, M.D. is an oncologist and a Professor, Division of Hematology/Oncology at Mayo Clinic Florida. He specializes in chronic leukemias such as CLL and CML, multiple myeloma and Waldenstrom's macroglobulinemia, and is the lead investigator for Phase 2 CLOVER-1 trial of CLR 131 in patients with relapsed/refractory `B-cell hematologic cancers. Dr. Ailawadhi was awarded the 2013 NCI CCITLA as an Assistant Professor of Medicine at the Norris Cancer Center, University of Southern California (USC), Los Angeles CA. Dr. Ailawadhi received his education from University College of Medical Sciences and Guru Teg Bahadur Hospital, University of Delhi and completed his residency at University College of Medical Sciences, University of Delhi and State University of New York at Buffalo. He completed his fellowship at Roswell Park Cancer Institute, State University of New York at Buffalo.
Related Talks
Evolving Treatment Paradigm of Multiple Myeloma
In the past decade, the FDA has approved 13 new agents and 29 treatments for multiple myeloma, which have transformed the treatment paradigm…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head…